/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Teva Pharmaceutical Industries Ltd Share Price Today: Live Updates & Key Insights

Teva Pharmaceutical Industries Ltd share price today is $28.73, up -2.41%. The stock opened at $29.64 against the previous close of $29.44, with an intraday high of $29.705 and low of $28.51.

Teva Pharmaceutical Industries Ltd Share Price Chart

style
pb-0

Teva Pharmaceutical Industries Ltd

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Teva Pharmaceutical Industries Ltd Share Price Performance

$28.73 -0.0241(-2.41%) TEVA at 23 Mar 2026 03:28 PM Drug Manufacturers - Specialty & Generic
Lowest Today 28.51
Highest Today 29.705
Today’s Open 29.64
Prev. Close 29.44
52 Week High 37.35
52 Week Low 12.47
Day’s Range: Low 28.51 High 29.705
52-Week Range: Low 12.47 High 37.35
1 day return -
1 Week return -2.57
1 month return -15.34
3 month return -7.96
6 month return +52.06
1 year return +77.49
3 year return +228.86
5 year return +140.75
10 year return -

Teva Pharmaceutical Industries Ltd Institutional Holdings

BlackRock Inc 4.96

Exor Investments (UK) LLP 4.91

Harel Insurance Invests & Fin Srvcs Ltd 3.86

Phoenix Financial Ltd 3.53

MENORA MIVTACHIM HOLDINGS LIMITED 3.38

Clal Insurance Enterprises Holdings Ltd 3.21

Migdal Insurance & Financial Holdings Ltd 3.21

NORGES BANK 3.02

FMR Inc 2.49

Rubric Capital Management LP 1.83

State Street Corp 1.47

Glenview Capital Management LLC 1.44

WCM Investment Management 1.20

Geode Capital Management, LLC 0.89

Altshuler Shaham Ltd 0.73

iShares Core MSCI EAFE ETF 0.69

Invesco S&P 500 ETF 0.68

Bank of America Corp 0.65

Schroder Investment Management Group 0.64

Wellington Management Company LLP 0.58

Morgan Stanley - Brokerage Accounts 0.56

Duquesne Family Office LLC 0.50

Fidelity Contrafund 0.47

EAFE Equity Index Fund T 0.47

WCM Focused International Growth Instl 0.39

American Funds New World A 0.37

Capital Group New Geography Equity Comp 0.37

Fidelity International Index 0.36

iShares MSCI EAFE ETF 0.34

Polar Capital Healthcare Opports Inc 0.33

Stt Strt World Dev ex US Idx SL SF Cl I 0.26

FAST - Global Fund I-PF-ACC-USD 0.25

Strategic Advisers Fidelity Intl 0.25

BGF World Healthscience A2 0.25

BlackRock Health Sciences Opps Inv A 0.24

Dynamic Global Dividend Series F 0.23

Fidelity Series International Value 0.23

Fidelity Contrafund Commingled Pl S 0.22

iShares MSCI Israel ETF 0.21

Blackrock EAFE Eq Idx Fund CF 0.21

Teva Pharmaceutical Industries Ltd Market Status

Strong Buy: 6

Buy: 4

Hold: 1

Sell: 0

Strong Sell: 0

Teva Pharmaceutical Industries Ltd Fundamentals

Market Cap 33460.07 M

PB Ratio 4.2301

PE Ratio 23.7438

Enterprise Value 48113.68 M

Total Assets 40747.37 M

Volume 6292907

Teva Pharmaceutical Industries Ltd Company Financials

Annual Revenue FY25:17257000000 17257.0M, FY24:16544000000 16544.0M, FY23:15846000000 15846.0M, FY22:14925000000 14925.0M, FY21:15878000000 15878.0M

Annual Profit FY25:8938000000 8938.0M, FY24:8064000000 8064.0M, FY23:7645000000 7645.0M, FY22:6973000000 6973.0M, FY21:7594000000 7594.0M

Annual Net worth FY25:1410000000 1410.0M, FY24:-1639000000 -1639.0M, FY23:-559000000 -559.0M, FY22:-2353000000 -2353.0M, FY21:417000000 417.0M

Quarterly Revenue Q4/2025:4711000000 4711.0M, Q3/2025:4480000000 4480.0M, Q2/2025:4176000000 4176.0M, Q1/2025:3891000000 3891.0M, Q4/2024:4229000000 4229.0M

Quarterly Profit Q4/2025:2656000000 2656.0M, Q3/2025:2304000000 2304.0M, Q2/2025:2102000000 2102.0M, Q1/2025:1877000000 1877.0M, Q4/2024:2120000000 2120.0M

Quarterly Net worth Q4/2025:480000000 480.0M, Q3/2025:433000000 433.0M, Q2/2025:282000000 282.0M, Q1/2025:214000000 214.0M, Q4/2024:-217000000 -217.0M

About Teva Pharmaceutical Industries Ltd & investment objective

Company Information Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Organisation Drug Manufacturers - Specialty & Generic

Employees 31173

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Richard D. Francis

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Teva Pharmaceutical Industries Ltd FAQs

What is the share price of Teva Pharmaceutical Industries Ltd today?

The current share price of Teva Pharmaceutical Industries Ltd is $28.73.

Can I buy Teva Pharmaceutical Industries Ltd shares in India?

Yes, Indian investors can buy Teva Pharmaceutical Industries Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Teva Pharmaceutical Industries Ltd shares in India?

You can easily invest in Teva Pharmaceutical Industries Ltd shares from India by:

Can I buy fractional shares of Teva Pharmaceutical Industries Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Teva Pharmaceutical Industries Ltd?

Teva Pharmaceutical Industries Ltd has a market cap of $33460.07 M.

In which sector does Teva Pharmaceutical Industries Ltd belong?

Teva Pharmaceutical Industries Ltd operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Teva Pharmaceutical Industries Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Teva Pharmaceutical Industries Ltd?

The PE ratio of Teva Pharmaceutical Industries Ltd is 23.74 and the PB ratio is 4.23.